Mylan Inc., a global pharmaceutical company committed to setting new
standards in health care, has launched atovaquone and proguanil
hydrochloride tablets, 62.5 mg/25 mg and 250 mg/100 mg, the generic
version of GlaxoSmithKline's Malarone tablets.
